Team:Marburg
From 2013.igem.org
m |
m |
||
Line 21: | Line 21: | ||
<div class="home"> | <div class="home"> | ||
<div class="home_youtube"> | <div class="home_youtube"> | ||
- | <a href="http://www.youtube.com/embed/mN9WnJ14-Yo" target="_blank">Video Introduction</a><br /> | + | <center><a href="http://www.youtube.com/embed/mN9WnJ14-Yo" target="_blank">Video Introduction</a></center><br /> |
<a href="http://www.youtube.com/embed/mN9WnJ14-Yo" target="_blank"> | <a href="http://www.youtube.com/embed/mN9WnJ14-Yo" target="_blank"> | ||
<img src="https://static.igem.org/mediawiki/2013/3/31/Mr-igem-youtube.png" alt="YouTube Video" /> | <img src="https://static.igem.org/mediawiki/2013/3/31/Mr-igem-youtube.png" alt="YouTube Video" /> | ||
Line 27: | Line 27: | ||
</div> | </div> | ||
<div class="home_cycle"> | <div class="home_cycle"> | ||
- | <a href="https://2013.igem.org/Team:Marburg/Human_Practice">Human Practice"></a><br /> | + | <center><a href="https://2013.igem.org/Team:Marburg/Human_Practice">Human Practice"></a></center><br /> |
<!--[if !IE]> --> | <!--[if !IE]> --> | ||
<div id="jquery-cycle" class="pics"> | <div id="jquery-cycle" class="pics"> |
Revision as of 18:28, 28 October 2013
The iGEM Marburg proudly presents: PHAECTORY
The use of proteins in medical treatment and diagnosis is steadily increasing. Many of these proteins (e.g. antibodies) have a complex biological structure, which complicates their production. Also, these proteins need to be highly pure. Therefore, a major challenge is the development of systems that produce complex proteins with high purity - best at low costs!The sunlight-driven microalgae Phaeodactylum tricornutum has been used for the production of complex proteins. A major advantage of the algae is its ability to secrete proteins directly into the medium. This feature would greatly simplify purification of recombinant proteins, and lower production costs! Here we take advantage of the excellent secretion abilities of P. tricornutum, and make this organism accessible to synthetic biology and the iGEM competition (PHAECTORY).
Furthermore, we used a light-inducible promoter which we have characterized quantitatively in order to control protein expression in PHAECTORY (Light control). Also, we introduced a transferable element to the registry, which allows autonomous targeting of proteins to the inner surface of cell membranes (Improve a Brick). We hope you enjoy reading about our project!
Our Sponsors